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Introduction: We aimed to evaluate the correlation between the size 
of the solid component on thin-section computed tomography (CT) 
and invasive component on pathology in small lung adenocarcino-
mas manifesting as subsolid nodules.
Methods: Fifty-nine subsolid nodules in 58 patients were evalu-
ated. The maximum diameters of subsolid nodules and the solid 
component on CT were measured by two radiologists in three-
dimensional (3D) and two-dimensional (2D) planes using in-
house software. In addition, the maximum diameters of the tumor 
and invasive component were measured on pathology by two 
pathologists. CT measurements were compared with pathologic 
measurements.
Results: There was a strong correlation between the size of 
the solid component on CT and invasive component on pathol-
ogy, as well as the size of subsolid nodules and the tumor size 
(r = 0.82–0.87 for 3D measurement, 0.72–0.88 for 2D measure-
ment; p < 0.0001). The size of subsolid nodules in 3D and 2D mea-
surements was significantly larger than tumor size (p < 0.0001). In 
regard to measurement of the solid component, 3D measurements 
tended to be larger than the size of the invasive component whereas 
2D measurement tended to be similar to the size of the invasive 
component. By applying a size criteria of solid component that 
was 3 mm or lesser in maximum diameter, preinvasive and mini-
mally invasive adenocarcinoma was predicted with a specificity of 
100% (28 of 28).
Conclusion: We found a significant correlation between the size of 
the solid component on thin-section CT and the invasive component 
on pathology.
Key Words: Subsolid nodule, Lung adenocarcinoma, Minimally 
invasive adenocarcinoma.
(J Thorac Oncol. 2014;9: 74–82)
Recently, a new classification of lung adenocarcinomas was proposed by the International Association for the Study 
of Lung Cancer, American Thoracic Society, and European 
Respiratory Society.1 In this classification, new concepts of 
adenocarcinoma in situ (AIS) and minimally invasive adeno-
carcinoma (MIA) were introduced. On the basis of the size of 
the invasive component and pathologic features, lung adeno-
carcinomas are now classified into four categories—prein-
vasive lesions, MIA, invasive adenocarcinoma, and variants 
of invasive adenocarcinoma. AIS and atypical adenomatous 
hyperplasia fall under the category of preinvasive lesions for 
lung adenocarcinoma. With preinvasive lesions and MIA, 
patients will have 100% or near-100% disease-specific sur-
vival, respectively, if completely resected. Furthermore, previ-
ously published data have shown that patients with preinvasive 
lesions or MIA may undergo less extensive surgery such as 
sublobar resection.2–9 However, to date, it is hard to make a 
diagnosis of preinvasive lesions or MIA with frozen biopsy 
specimens, as the invasive component should be precisely 
evaluated using the entire pathologic sampling. Thus, if pre-
operative imaging is able to predict the invasive component 
of adenocarcinomas, it will have great clinical value in deter-
mining the extent of surgical resection as well as the patient’s 
prognosis.
“Subsolid nodule” is a more comprehensive term 
than “part-solid nodule.” Subsolid nodule refers to both 
pure ground-glass nodule (GGN) and part-solid GGN, as 
a category separated from purely solid nodule. Part-solid 
GGN indicates the nodule that has both ground-glass and 
solid components.10 In subsolid nodules, many previous 
reports have demonstrated that ground-glass opacity (GGO) 
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components represent the lepidic growth and that solid com-
ponents are frequently related with invasion11–23 and also note 
that computed tomography (CT) plays an important role in 
the management of subsolid nodules.10 It has also been sug-
gested that the T staging in the Tumor Node Metastasis clas-
sification should be adjusted radiologically by measuring 
the solid component of subsolid nodules1 and that the man-
agement of subsolid nodules should be based on the size of 
subsolid nodules and the solid component.10 The comparison 
of radiologic–pathologic tumor measurements conducted in 
several other cancers has demonstrated that radiologic mea-
surement significantly corresponded with pathologic tumor 
size and may be valuable in treatment planning.24–29 To our 
knowledge, however, no previous study has provided and 
directly correlated the measurement data between the solid 
component of subsolid nodules on thin-section CT and the 
invasive component on pathologic exams.
Therefore, the purpose of our study was to evaluate the 
correlation between the size of the solid component on thin-
section CT and the invasive component on pathology in small 
lung adenocarcinomas and preinvasive lesions manifesting as 
subsolid nodules.
MATERIALS AND METHODS
This study was approved by the Institutional Review 
Board of our institution, and written informed consent was 
waived for all patients in this retrospective study.
Selection of Cases
We retrospectively reviewed the medical records of all 
patients who had undergone surgical resection for small lung 
adenocarcinomas and preinvasive lesions that manifested as 
subsolid nodules on CT at our hospital between August 2005 
and June 2011. We defined small adenocarcinomas as measur-
ing 3 cm or lesser on the basis of pathologic report. All the 
tumors had T stage of T1 or lower in our study population. 
There was a total of 141 eligible patients for whom pathology 
slides were available. Among them, we excluded 83 patients 
based on our exclusion criteria defined as follows: (1) time 
between CT and surgery of more than 4 weeks (n = 11) and (2) 
patients who were considered to have inappropriate CT images 
for subsolid nodule analysis (section thickness > 1.25 mm, CT 
images scanned at outside hospitals or reconstructed with 
different algorithms; n = 72). Finally, a total of 58 patients 
(19 men and 39 women) (median age, 61 years; range, 
26–85 years) were included in our study. Surgical procedures 
included wedge resection in 13 patients and lobectomy in 45 
patients. The mean time ± standard deviation between CT and 
surgery was 14.2 ± 12.5 days.
Through the surgical records and transverse CT images, 
one chest radiologist (JMG) with 21 years of experience read-
ing chest CT images and one radiology resident in her fourth 
year of training (KHL) identified the location of correspond-
ing subsolid nodules on CT images by consensus. Images 
were displayed by using a lung window setting with a cen-
ter of −700 HU and a width of 1500 HU. When there were 
multiple subsolid nodules per patient, only subsolid nodules 
with pathologic confirmation of lung adenocarcinomas were 
selected based on surgical records. All patients had a single 
subsolid nodule with pathologic confirmation, except one 
patient who had two subsolid nodules with pathologic proof. 
Finally, a total of 59 subsolid nodules were selected in 58 
patients for image analysis. The study population and subsolid 
nodules enrolled in our study partly overlap with those of our 
previous reports from our department.30,31 However, the meth-
odology is totally different from that of prior studies.
Image Acquisition
CT images were obtained using one of the following 
four CT scanners; Sensation 16 (Siemens Medical Solutions, 
Forchheim, Germany), Somatom Definition (Siemens 
Medical Solutions, Forchheim, Germany), LightSpeed Ultra 
(GE Healthcare, Milwaukee, WI), or Brilliance 64 (Philips 
Medical Systems, Best, The Netherlands). As all data were 
collected retrospectively, a variety of scanning protocols were 
used, including CT with (n = 35) or without (n = 23) intrave-
nous contrast material, and CT with standard-dose (n = 45) or 
low-dose techniques (n = 13). Tube current ranged from 200 
to 400 mAs for standard-dose techniques and 20 to 40 mAs 
for low-dose techniques, with tube voltage of 120 kV for all 
scans. In all patients, CT images were reconstructed using the 
high-frequency algorithm with a section thickness of 1.25 mm 
or l mm. The image matrix size ranged from 512 × 512 pixels. 
The field of view was optimized for the size of the patients and 
ranged from 300 to 350 mm.
Assessment of CT Scans
For the 59 subsolid nodules, two radiologists (Reader 
1: a radiology resident (KHL); Reader 2: a chest radiologist 
(JYW), with 5 years of experience) independently drew the 
borders of subsolid nodules as well as the solid component 
and saved them as regions of interest files by using in-house 
software. On the basis of the regions of interest of subsolid 
nodules drawn by radiologists for the whole boundary of 
subsolid nodules and their solid components, the program 
automatically calculated the maximum diameter in both 
(three-dimensionsal) 3D and (two-dimensional) 2D planes 
and showed the axis of the maximum diameter of subsolid 
nodules. Two readers then reviewed the measurement results 
and axes of the maximum diameter generated by the program 
in all cases and were allowed to adjust the measurements by 
manually drawing the maximum diameter if the generated 
results were deemed unacceptable because of long spicula-
tions of subsolid nodules in a few cases.
To assess intrareader variability, Reader 1 outlined the 
boundary of the subsolid nodules as well as the solid compo-
nent on the CT scans over two sessions (Fig. 1): in the first 
session, she drew a border around all involved CT sections 
that contained subsolid nodules to obtain both 3D and 2D 
measurement data, and in the second session, she only out-
lined the border of the subsolid nodules and the solid com-
ponent on the representative CT image with the largest long 
diameter of subsolid nodules. For cases in which the slice of 
the maximum dimension of the solid portion was different 
from that of the maximum dimension of subsolid nodule, she 
drew a border around the solid component on the slice of 
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the largest diameter of the solid portion. There was a 4-week 
interval between the first and second session. To evaluate 
interreader variability, Reader 2 drew the boundary of each 
subsolid nodule and solid component once on a single CT 
image with the maximum long diameter of subsolid nodules. 
If multiple separate areas of solid components were present, 
the border of the largest solid component was outlined. If a 
large blood vessel was present, the readers attempted not to 
include the blood vessel.
Pathologic Assessment
All surgical specimens were fixed in an inflated state 
by means of transpleural and transbronchial infusion of 10% 
buffered formalin and embedded in paraffin. The specimens 
were stained with hematoxylin and eosin. For each case, a 
representative pathologic slide (chosen by HSP, who had 
6 years of experience) containing the largest cross-section 
or representative part of the tumor, was selected. Examined 
under light microscopy, the borders of the tumor and invasive 
component were drawn on pathology slides by two patholo-
gists (HSP and HJG, who too had 6 years of clinical experi-
ence) in consensus (Fig. 1). Thereafter, all pathology slides 
were scanned in 1:1 scale along with a transparent millimeter 
ruler and digitized using a software package (Image-J, ver-
sion 1.37v, for Windows http://www.ncbi.nlm.nih.gov/). With 
use of the software, K.H.L. manually redrew the tumor bor-
ders along the indicators that the pathologists had marked on 
pathology slides and measured the maximum diameter of the 
tumor and invasive component. The final pathologic diagnoses 
were determined postoperatively by a retrospective pathologic 
review of all specimens by the two pathologists, according to 
the new adenocarcinoma classification.1
Exploratory Analysis
We conducted additional exploratory analyses and eval-
uated the specificity and sensitivity of CT measurements in 
predicting preinvasive and MIA lesions.
Statistical Analysis
For comparison, the mean measurements of subsolid 
nodules and solid components were used. Measurement data 
on CT was compared with the pathologic reference diameter 
using the paired t test (a parametric test was used because data 
were observed to be normally distributed) and Pearson’s cor-
relation test.
Interreader variability and intrareader variability for the 
measurements on CT were analyzed by calculating the intra-
class correlation coefficient (ICC) (0–0.20, poor correlation; 
0.21–0.40, fair correlation; 0.41–0.60, moderate correlation; 
0.61–0.80, good correlation; and 0.81–1.00, excellent correla-
tion) and 95% Bland-Altman limits of agreement.32 The one-way 
analysis of variance test was used to compare the measurement 
data on CT according to lung adenocarcinoma categorization. 
All statistical analysis was performed using two commer-
cially available software programs (SPSS 18.0 for Windows, 
SPSS, Chicago, IL, and MedCalc 12.1.4.0, MedCalc Software, 
Mariakerke, Belgium). For all studies, a difference with a p value 
of less than 0.05 was considered statistically significant.
FIGURE 1. A and B, Axial com-
puted tomography image showing a 
peripheral ground-glass opacity and 
a central area of increased attenua-
tion. Readers manually outlined the 
subsolid nodule (yellowish green) 
and its solid component (yellow), 
which was used to calculate the 
maximum diameter. C and D, A 
digitized image of the representa-
tive pathologic slide revealed that 
this part-solid GGN was an invasive 
adenocarcinoma. The border of the 
overall tumor (marked by blue dots) 
and the invasive component (marked 
by red dots) was manually drawn 
by two pathologists in consensus. 
(Hematoxylin–eosin stain; original 
magnification in (C) ×1.0; and (D) 
×40.) GGN, ground-glass nodule; 
ADC, adenocarcinoma.
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RESULTS
Nodule Characteristics
Of 59 subsolid nodules, 44 cases were part-solid GGNs 
and 15 were pure GGNs on CT. Pathologic exam revealed 16 
preinvasive lesions (3 atypical adenomatous hyperplasia and 
13 AIS), 15 MIA, and 28 invasive adenocarcinomas. The means 
tumor size ± standard deviations described in the pathologic 
reports were 8.9 mm ± 4.2 in preinvasive lesions, 13.4 mm ± 
3.4 in MIA, and 16.9 mm ± 4.6 in invasive adenocarcinomas.
CT and Pathology Measurement
The maximum diameter of subsolid nodules and the 
solid component in the 3D plane is abbreviated as 3D Nodule 
and 3D Solid. On axial CT images with the maximum diameter 
of subsolid nodules, the size of subsolid nodules and the solid 
component was measured and is shown as 2D Nodule and 2D 
Solid. 2D Solid 
largest
 represents the maximum diameter of the 
solid component on axial CT images regardless of the size of 
subsolid nodules. The relationship between CT and pathologic 
measurements is presented in Table 1. A significant correlation 
was noted in the maximum diameter of subsolid nodules on CT 
and tumor size on pathology (r = 0.82 for 3D measurement, 
0.81–0.82 for 2D measurement; p < 0.0001). Moreover, there 
was a significant correlation in maximum diameter between the 
solid component on CT and the invasive component on pathol-
ogy (r = 0.87 for 3D measurement, 0.72–0.88 for 2D measure-
ment; p < 0.0001). The strongest correlation was obtained for 
2D Solid 
largest
 measurement (r = 0.88).
In this study, CT images showed a tendency to display 
the tumor size in its larger diameter on both 3D and 2D mea-
surements. For tumor size measurements, differences in maxi-
mum diameter between CT and pathology measurements were 
significant (mean difference, 10.38 mm for 3D; 4.93~6.05 mm 
for 2D; p < 0.0001). With regard to solid component mea-
surement, 3D measurements tended to overestimate the inva-
sive component whereas 2D measurements tended to display 
the invasive component in a similar diameter. For the solid 
component, the difference in maximum diameter between 3D 
CT and pathology measurements was significant (mean dif-
ference, 4.23 mm for 3D measurement, p < 0.0001). With 2D 
measurements, there were no significant differences between 
the pathology measurements for 2D Solid 
largest
 measurement 
during the second session by Reader 1 (mean difference 
−0.22 mm) and 2D Solid measurement (−0.18 mm) by Reader 
2 (p > 0.05). However, significant differences were noted for 
2D Solid (mean difference, −1.28 mm, p = 0.02), 2D Solid 
largest
 
(1.21 mm, p = 0.003) during the first session, and 2D solid 
(−1.42 mm, p = 0.02) during the second session by Reader 1.
Interreader and Intrareader Variability
Both interreader and intrareader agreements in CT 
measurements were excellent (ICC range, 0.92–0.98). Bland-
Altman plots with 95% limits of agreement are shown in 
Figs. 2 and 3. In general, scatter of measurement differences 
around the mean was independent of tumor diameter.
Lung Adenocarcinoma Categorization
Of the 15 MIA cases, 10 cases were part-solid GGNs 
and five were pure GGNs on CT.  The mean size of the solid 
component in MIAs was 4.9 mm (range, 0–9.6 mm), 2.4 mm 
(0–8.0 mm), and 3.6 mm (0–7.8 mm) on 3D Solid, 2D Solid, 
and 2D Solid 
largest
 measurements, respectively. In five MIA 
cases manifesting as pure GGNs, the size of the invasive com-
ponent was 1.4, 1.4, 3.0, 3.4, and 4.3 mm on pathology.
TABLE 1.  Mean Difference and Correlation Coefficient for Measured Diameters on CT and Pathology
Reader and Measurement Variable
Mean Measurement Difference (mm)a  
= CT Diameters Minus Pathology Diameters p Valueb Correlation Coefficient
Reader 1_1st session
  3D Nodule 10.38 (8.95, 11.81) <0.0001c 0.82
  2D Nodule 6.05 (5.05, 7.05) <0.0001c 0.82
  3D Solid 4.23 (2.99, 5.47) <0.0001c 0.87
  2D Solid −1.28 (−2.36, −0.20) 0.02c 0.77
  2D Solid
largest
1.21 (0.42, 1.99) 0.003c 0.88
Reader 1_2nd session
  2D Nodule 4.93 (3.98, 5.87) <0.0001c 0.81
  2D Solid −1.42 (−2.58, −0.26) 0.02c 0.74
  2D Solid
largest
−0.22 (−1.23, 0.79) 0.67 0.8
Reader 2
  2D Nodule 5.69 (4.63, 6.75) <0.0001c 0.81
  2D Solid −0.18 (−1.42, 1.05) 0.77 0.72
The maximum diameter of subsolid nodules and solid component in 3D plane is abbreviated to 3D Nodule and 3D Solid. 2D Nodule and 2D Solid represents the size of subsolid 
nodule and solid component on axial CT image with the maximum diameter of subsolid nodule. 2D Solid 
largest
 represents the maximum diameter of solid component on axial CT image, 
regardless of the size of subsolid nodule.
aNumbers in parentheses are the 95% confidence interval.
bPaired t test.
cSignificant difference.
2D, two-dimensional; 3D, three-dimensional; CT, computed tomography.
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To identify useful CT measurements in predicting pre-
invasive lesions or MIAs, we compared the CT measurements 
of the preinvasive, MIA, and invasive adenocarcinoma groups 
(Table 2). All pure GGNs were confirmed as either preinva-
sive lesions (67%, 10 of 15) or MIAs (33%, 5 of 15). In the 
invasive adenocarcinoma group, all lesions included a solid 
portion and presented as part-solid GGNs. With regard to 
CT measurements, all measurements showed significant dif-
ferences among the three groups (p < 0.0001). On subgroup 
analysis, the invasive adenocarcinoma group showed a larger 
size of subsolid nodules, solid component, and a higher size 
ratio of solid component to subsolid nodules than the preinva-
sive lesion and MIA groups. There were no significant differ-
ences in CT measurements between the preinvasive lesion and 
MIA groups (p > 0.05).
Radiologic Measurement in Predicting 
Preinvasive and MIA Lesions
Additional exploratory analysis was performed to 
determine 2D CT measurement values useful in predicting 
preinvasive and MIA lesions with high specificity (Table 3). 
The highest specificity of 100% (28 of 28) was observed 
with a size criteria of Solid 
largest
 of 3 mm or lesser. All the 
invasive lung adenocarcinomas included the solid portion 
larger than 3 mm in largest diameter. When a size criteria 
of Solid 
largest
 of 5 mm or lesser was applied, three invasive 
lung adenocarcinomas were categorized under the radiologi-
cal preinvasive and MIA groups, resulting in a specificity of 
89% (25 of 28). We also examined the measurement criteria 
that was previously suggested by Suzuki et al.11 When the 
criteria of subsolid nodules of 20 mm or lesser with a solid 
component of 0.25 or lesser to the maximum diameter of 
subsolid nodule was applied, it also showed 100% specificity 
(28 of 28) in predicting preinvasive and MIA lesions.
DISCUSSION
In this retrospective study, we correlated the CT and 
pathologic measurements of small adenocarcinomas mani-
festing as subsolid nodules, and investigated the CT measure-
ments according to the lung adenocarcinoma categorization. 
The main findings of this study are: (1) The size of subsolid 
nodules and solid components on CT significantly correlated 
with that of the tumor and invasive component on pathology in 
small lung adenocarcinomas; (2) 3D measurements of the size 
of the solid component showed a tendency to be larger than 
the size of the invasive component, whereas 2D measurements 
tended to be similar to the size of the invasive component; and 
(3) A size criteria of Solid 
largest
 3 mm or lesser may predict 
preinvasive and MIA lesions with high specificity.
For the differences between CT and pathology mea-
surements observed in our data, there are several possible 
explanations. First, in addition to the variability of CT mea-
surements in lung nodules,33,34 the most important factor may 
be that the inflation state of lung tissues was different from 
the in vivo state as the resected specimens were obtained from 
deflated lung tissue and had shrunk and deformed during tis-
sue processing. Second, although we selected the representa-
tive pathology slide that contained the largest cross-section, 
some parts of the tissue specimen were impaired during fro-
zen biopsy in operation, or the largest dimension of the tumor 
may not have been evaluated as we did not evaluate thin, con-
secutive sections of pathologic slides. Third, the plane of the 
section of the pathologic specimen may not have been accu-
rately aligned with the CT scan. In our routine clinical prac-
tice, pathologic specimens are roughly cut into the section that 
contains the largest cut surface of the tumor in most cases. 
Finally, not only the invasive component but also the collapsed 
alveolar space, fibrosis, or mucin component may have pre-
sented as a solid portion on CT. Therefore, the solid portion 
on CT may have shown a larger diameter than the pathologic 
FIGURE 2.  Bland-Altman plots showing interreader agreement of two-dimensional size measurements for subsolid 
nodules (A) and the solid component (B). X axes show mean measurements and y axes show differences between 
 measurements of the two readers. Solid lines = mean absolute differences. Dashed lines = 95% limits of agreement. 
GGN, ground-glass nodule.
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size of the invasive component. However, even though some 
CT measurements showed significant differences from pathol-
ogy measurements because of the reasons described above, 
our results demonstrated that the correlation between CT and 
pathology measurements were significant.
Until now, there has been very little research conducted 
to correlate radiologic and pathologic measurements in lung 
adenocarcinoma.35–37 Our data are consistent with previous 
reports in that CT measurements tended to overestimate the 
true pathologic size of the tumors with a significant differ-
ence.37,38 Furthermore, in this study, 3D solid CT measure-
ments also showed a tendency to overestimate the invasive 
component, whereas 2D solid CT measurements tended to be 
similar to the size of the invasive component. To date, however, 
the optimal window setting for assessing tumor size or the 
invasive component has not been clarified. Therefore, with our 
study population, we examined new window settings for the 
optimal evaluation of subsolid nodules and solid components 
on thin-section CT (Appendices 1–3, Supplementary Digital 
Content 1, http://links.lww.com/JTO/A520). In the evaluation 
of subsolid nodule size, GGN setting 1 (−520, 1) was the most 
accurate in determining the pathology tumor size. Because of 
the wide variety of CT attenuation values of GGOs and the 
lower contrast of GGOs against the surrounding pulmonary 
parenchyma compared with the solid portion, setting a fixed 
CT attenuation cutoff value for the subsolid nodule boundary 
may have contributed to a more precise measurement. Further 
studies are needed to validate the clinical application of this 
window setting. In the estimation of the solid component, we 
found that the size of the solid component displayed at the 
lung window setting (LWS; −700, 1500) better correlated 
with that of the invasive component than other window set-
tings. Thus, when assessing the size of the solid portion in 
part-solid GGNs, we believe that LWS (−700, 1500) itself may 
FIGURE 3.  Bland-Altman plots showing intrareader agreement of two-dimensional size measurements for subsolid nodules 
(A), solid component (B), and solid largest (C). X axes show mean measurements and y axes show differences between measure-
ments of the two reading sessions by Reader 1. Solid lines = mean absolute differences. Dashed lines = 95% limits of agreement. 
GGN, ground-glass nodule.
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be sufficient to predict the size of the invasive component on 
pathology.
There have been attempts to separate preinvasive ade-
nocarcinoma from invasive carcinoma by measuring tumor 
dimensions on CT. Suzuki et al.11 reported that lung carci-
noma that was 2.0 cm or lesser in size and with a consolida-
tion of 25% of lesser of the maximum tumor diameter was 
considered to be radiological early lung cancer. In pure GGNs, 
8 mm and 10 mm have been suggested as thresholds that 
showed high specificity in differentiating premalignant lesions 
from malignant lesions and preinvasive lesions from invasive 
adenocarcinomas, respectively.30,31 However, CT findings or 
measurement thresholds for MIAs have not been reported. In 
our study, MIA appeared as pure GGNs in one third of cases 
(5 of 15) and presented as part-solid GGNs consisting of a 
predominant GGO component and a small central solid com-
ponent in two thirds of cases (10 of 15). On quantitative analy-
sis, our data showed that there was no significant difference 
in the maximum diameter of subsolid nodules and the solid 
component between MIAs and preinvasive lesions. On the 
contrary, invasive lesions showed significantly larger subsolid 
nodule size and solid component than preinvasive and MIA 
lesions. On the basis of these different imaging characteris-
tics, we believe that thin-section CT may be able to predict 
preinvasive and MIA lesions preoperatively, so as to deter-
mine the eligibility of patients for limited surgical resection. 
To avoid patients undergoing limited resection for invasive 
adenocarcinomas, specificity was considered the most impor-
tant factor. Both of a size criteria of solid 
largest
 3 mm or lesser 
and the measurement criteria previously suggested by Suzuki 
et al.,11 subsolid nodules that were 20 mm or lesser with a 
solid component of 0.25 or lesser to the maximum diameter, 
showed 100% specificity. As measuring the size of the solid 
component in largest diameter is a more convenient and sim-
pler way than measuring and calculating the ratio of two vari-
ables, we suggest that a size criteria of Solid 
largest
 of 3 mm 
or lesser may be a safe and useful radiologic measurement in 
predicting preinvasive and MIA lesions preoperatively with 
high specificity. We anticipate that the diagnostic accuracy of 
these radiologic measurements as well as the precise role of 
TABLE 2.  CT Measurement Comparison between Preinvasive, MIA, and Invasive Groups
Preinvasive (n=16) MIA (n=15) Invasive (n=28) p Valuea
p Valueb
Preinvasive  
vs. MIA
 Preinvasive 
vs. Invasive 
MIA vs.  
Invasive 
Subsolid nodule 
classification
<0.0001 0.16 <0.0001 0.003
  Pure GGNs, no. (%) 10 (63%) 5 (33%) 0 (0%)
  Part-solid GGNs, 
no. (%)
6 (37%) 10 (67%) 28 (100%)
CT diameter (mm)
  3D Nodule 5.2–26.7 (15.8 ± 6.9) 11.1–30.6 (20.9 ± 5.4) 16.0–45.1 (29.2 ± 7.2) <0.0001 0.07 <0.0001 <0.0001
  3D Solid 0–12.1 (2.5 ± 3.8) 0–9.6 (4.9 ± 4.0) 8.8–30.6 (18.6 ± 6.3) <0.0001 0.08 <0.0001 <0.0001
  3D Solid/Nodule 0–0.59 (0.16 ± 0.23) 0–0.46 (0.23 ± 0.18) 0.28–0.96 (0.64 ± 0.16) <0.0001 0.38 <0.0001 <0.0001
  2D Nodule 4.6–24.5 (12.8 ± 5.4) 9.4–25.2 (17.3 ± 5.2) 13.2–32.1 (22.6 ± 4.7) <0.0001 0.014 <0.0001 0.004
  2D Solid 0–6.0 (1.5 ± 2.0) 0–8.0 (2.4 ± 3.1) 0–20.9 (9.5 ± 6.0) <0.0001 0.51 <0.0001 0.0002
  2D Solid/Nodule 0–0.54 (0.12 ± 0.16) 0–0.55 (0.13 ± 0.17) 0–0.80 (0.41 ± 0.23) 0.0001 0.84 0.0002 0.0005
  2D Solid
largest
0–7.3 (1.6 ± 2.5) 0–7.8 (3.6 ± 3.0) 3.7–21.2 (11.9 ± 4.9) <0.0001 0.06 <0.0001 <0.0001
  2D Solid
largest
/Nodule 0–0.57 (0.13 ± 0.20) 0–0.53 (0.21 ± 0.17) 0.22–0.83 (0.52 ± 0.17) <0.0001 0.3 <0.0001 <0.0001
Unless otherwise specified, data are range (mean values ± standard deviations). Three-dimensional and 2D Solid/Nodule is the ratio of the maximum diameter of solid component 
to that of subsolid nodules in 3D plane and 2D plane, respectively.
aCalculated using the χ2 test in comparing the adenocarcinoma classification and the one-way analysis of variance test in comparing CT diameter.
bCalculated using Tukey post hoc comparison tests.
CT, computed tomography; 2D, two-dimensional; 3D, three-dimensional; MIA, minimally invasive adenocarcinoma. 
TABLE 3.  Diagnostic Accuracy of the Two-Dimensional Measurement Criteria in Predicting Pathological Preinvasive and MIA 
Lesions
Solid
largest
 ≤ 5 mm Solid
largest
 ≤ 3 mm
Subsolid Nodule ≤ 20 mm 
with ≤ 0.25 Solid Component
Sensitivity 61% (19/31, 95% CI: 47–73) 42% (13/31, 95% CI: 25–61) 42% (13/31, 95% CI: 25–61)
Specificity 89% (25/28, 95% CI: 78–96) 100% (28/28, 95% CI: 88–100) 100% (28/28, 95% CI: 88–100)
PPV 88% (23/26, 95% CI: 77–95) 100% (13/13, 95% CI: 75–100) 100% (13/13, 95% CI: 75–100)
NPV 76% (25/33, 95% CI: 63–86) 61% (28/46, 95% CI: 46–75) 61% (28/46, 95% CI: 46–75)
Numbers in parentheses are numerators/denominators, 95% CI.
CI, confidence interval; MIA, minimally invasive adenocarcinoma; PPV, positive predictive value; NPV, negative predictive value.
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limited resection may be better confirmed in future random-
ized prospective trials.
There are some limitations to our study. First, as our patient 
evaluation was retrospective, there was unavoidable selection 
bias. Second, a relatively small number of patients were evalu-
ated in this study. Third, we used a single representative pathol-
ogy slide for each case, which was not sectioned in the same 
axial plane of CT scans, limiting accuracy in correlating CT and 
pathology measurements. However, this was unavoidable in our 
study, as pathologists had not thoroughly measured the size of 
the invasive component during routine clinical practice before 
the concept of MIA had emerged. To overcome this limitation, 
we obtained various CT measurements, including both 3D and 
2D. We believe that this limitation can be overcome in a further 
prospective study, in which pathologic specimens are consecu-
tively sectioned in the same transaxial plane as the CT scan.
In conclusion, we found a significant correlation 
between the size of the solid component on thin-section CT 
and the invasive component on pathology in small lung adeno-
carcinomas manifesting as subsolid nodules.
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